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Stand-first:  The concept of risk should be used carefully in addiction science, policy and debate due 
to its complexity and its potential to inform, distort or otherwise shape the perspectives of 
stakeholders, including the general public.   Recent high profile examples from the UK demonstrate 
such care is often not being taken. 
 
  
On risk in addiction science, policy and debate  
The concept of risk should be used carefully in addiction science, policy and debate due to its 
complexity and its potential to inform, distort or otherwise shape the perspectives of stakeholders, 
including the general public.   Recent high profile examples from the UK demonstrate such care is 
often not being taken. 
The concept of risk plays a central role in addiction science, policy and debate. Risk is critical to our 
understanding of the harmfulness of addictive substances and behaviours and the design of 
appropriate preventative policies. However, risk is a complex concept. Its statistical malleability 
means presentation of risks in absolute or relative terms, or in comparison to potential harms of 
everyday activities, can inform, distort or otherwise stimulate debate [1]. Risks also do not exist only 
in numerical form. They are embodied through sensations of fear, apprehension, excitement and 
success. They are interpreted differently depending upon the ĐŽŵŵƵŶŝĐĂƚŽƌ ?Ɛcredibility in the eyes 
of the recipient, such that past behaviours or institutional identities (e.g. industry or government) 
may undermine even robustly evidenced and appropriately communicated messages [2]. 
Professional and lay decision-making engage with risk but are subject to numerous biases and often 
limited statistical understanding [3]. Finally, risk is socially constructed through discourse, with 
reference to everyday activities, past experienĐĞĂŶĚĂŶŽŵĂůŽƵƐĐĂƐĞƐƐƵĐŚĂƐ ‘ƚŚĞŽůĚůĂĚǇǁŚŽ
ƐŵŽŬĞĚĞǀĞƌǇĚĂǇďƵƚůŝǀĞĚƚŽĂŚƵŶĚƌĞĚ ? [4].  
Risk then, is to be treated carefully, perhaps more so in an age where political processes, journalism 
and scientific authority face major threats. Risk messages should be proportionately compelling and 
informed by an awareness of the likely and desired responses of recipients and conduits, such as 
news and social media. However, three high profile UK-based examples illustrate common failings: 
1. E-cigarettes: Debate around e-cigarettes is partly a disagreement in good faith about how to 
respond to an external shock to tobacco control policy. The stakes are heightened by threats 
to professional identity as influence partially shifts from public health actors to vapers, 
markets and the tobacco industry. Nonetheless, claims about the risks of e-cigarettes have 
been starkly inconsistent. For example, the consensus-based statement by Public Health 
England that e-cigarettes are  ‘ ? ?йƐĂĨĞƌ ?ƚŚĂŶƚƌĂĚŝƚŝŽŶĂůĐŝŐĂƌĞƚƚĞƐ[5] has been attacked 
and defended in the Lancet and BMJ, with the dispute reported prominently in UK news 
outlets [6, 7].  
2. Alcohol and cancer: In widely reported remarks, the Chief Medical Officer (CMO) for 
England told a UK parliamentary committee that people should decide each time they drink 
alcohol,  ?do I want my glass of wine or do I want to raise my risk of breast cancer? ? [8] 
Setting aside the incorrectly stated choice and poor correspondence with evidence on the 
automatic and heuristically-driven processes by which behavioural choices are typically 
made [9], similarly abstemious advice is offered by the World Cancer Research Fund (WCRF) 
who recommend  ‘ŽŶ ?ƚĚƌŝŶŬĂůĐŽŚŽů ?ĂƐ ‘ĂŶǇĂŵŽƵŶƚŝŶĐƌĞĂƐĞƐǇŽƵƌ ?ĐĂŶĐĞƌ ?ƌŝƐŬ ? [10].  
3. New psychoactive substances (NPS): The UK ?ƐPsychoactive Substances Act, 2016 subjects 
all non-exempt NPS to control due to their psychoactivity rather than their potential 
harmfulness. While we acknowledge there are gaps in scientific data, the Act also presents 
risks from a diverse range of drugs (e.g. novel opioids and nitrous oxide) as equivalent [11].  
These examples illustrate four problems with contemporary addiction-related risk discourse.  
First, there is a lack of attention to absolute levels of risk. Neither the CMO nor WCRF quantify risks 
alongside their statements. However, Cancer Research UK estimate that drinking a small glass of 
ǁŝŶĞĞĂĐŚĚĂǇ ?ĂƉƉƌŽǆŝŵĂƚĞůǇ ? ?ŐŽĨĂůĐŽŚŽů ?ŝŶĐƌĞĂƐĞƐƚŚĞĂǀĞƌĂŐĞh<ĂĚƵůƚ ?ƐĂďƐŽůƵƚĞůŝĨĞƚŝŵĞƌŝƐŬ
of being diagnosed with mouth cancer from 0.5% to 0.6%, while the equivalent breast cancer risk for 
women would increase from 11.1% to 11.7% [12]. Given that a large proportion of drinkers consume 
less than this, that alcohol consumption at these levels may benefit cardiovascular health (albeit to a 
lesser extent and more selectively than some studies suggest) and that alcohol epidemiology is 
highly imprecise [13], the justification for alarmist or proscriptive guidance is unclear.  
Second, risk acceptability is rarely explicitly discussed despite its importance for judging when risks 
are adequately managed and campaigns for additional controls should stop [14]. For example, the 
World Health Organisation has noted that e-ĐŝŐĂƌĞƚƚĞƐĂƌĞ ‘ƵŶůŝŬĞůǇƚŽďĞŚĂƌŵůĞƐƐ ? [15], but 
unquestioned everyday activities, such as sports, travel and showering, also entail risks, so the value 
of harmlessness as a standard for judging risks is questionable [16]. For illicit drugs, discussion of risk 
acceptability is limited by poor understanding among the public and policy-makers of their potential 
pleasures and harms, alongside often narrow frames for considering risks (e.g. overdose, addiction). 
In contrast, alcohol drinking guidelines have recently been set with reference to levels of risk 
apparently accepted for other activities (e.g. driving), but little direct evidence on acceptable risks 
from alcohol is available [13, 17].  
Third, a tension exists between population- and individual-level risk. ZŽƐĞ ?Ɛinfluential prevention 
paradox demonstrates that small behavioural changes among low risk individuals can produce large 
health gains for populations [18]. However, this logic of pooled risk reduction sits uneasily with the 
increased responsibility for health placed on individuals by policy-makers in many high-income 
countries [19]. If individuals are to engage in, and be judged on, the active, life-long self-
management of their health, it is unclear how they should make use of often contradictory and 
incomplete information about small and uncertain risks associated with particular patterns and 
levels of addictive substance use.  
Finally, risk is experienced as well as measured. Lay epidemiological perspectives emphasise that 
public engagement with risk is not a statistical process but one rooted in biography, experience, 
context, discourse and bodily sensation [4]. Addictive substance use does not typically reflect a devil 
may care attitude but pleasurable sensations, an occasional reward to oneself or an environment 
where health warnings are received sceptically, in competition with other information or nor at all. 
Statements on risk which fail to account for this wider context may face rejection, distortion or being 
ignored. 
Ultimately, these problems suggest a need for scientists, policy-makers and public authorities to 
attend more to the complex nature of risk. The current focus on epidemiological statistics and 
persistence of normative practices which portray all risks as important to the public, irrespective of 
scale, certainty, nature and context, mean the greatest risks may be that people stop listening, that 
hard-earned scientific credibility is squandered and that policy-making staggers erratically between 
laissez-faire neglect and heavy-handed overkill.  
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